Literature DB >> 1309747

Topoisomerase II plays an essential role as a swivelase in the late stage of SV40 chromosome replication in vitro.

Y Ishimi1, K Sugasawa, F Hanaoka, T Eki, J Hurwitz.   

Abstract

The effects of topoisomerases I and II on the replication of SV40 DNA were examined using an in vitro replication system of purified proteins that constitutes the monopolymerase system. In the presence of the two topoisomerases, two distinct nascent DNAs were formed. One product arising from the replication of the leading template strand was approximately half the size of the template DNA, whereas the other product derived from the lagging template strand consisted of short DNAs. These products were synthesized from both SV40 naked DNA and SV40 chromosomes. For the replication of SV40 naked DNA, either topoisomerase I or II maintained replication fork movement and supported complete leading strand synthesis. When SV40 chromosomes were replicated with the same proteins, reactions containing only topoisomerase I produced shorter leading strands. However, mature size DNA products accumulated in reactions supplemented with topoisomerase II, as well as in reactions containing only topoisomerase II. In the presence of crude extracts of HeLa cells, VP-16, a specific inhibitor of topoisomerase II, blocked elongation of the nascent DNA during the replication of SV40 chromosomes. These results indicate that topoisomerase II plays a crucial role as a swivelase in the late stage of SV40 chromosome replication in vitro.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309747

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Topoisomerase II can unlink replicating DNA by precatenane removal.

Authors:  I Lucas; T Germe; M Chevrier-Miller; O Hyrien
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

2.  Cellular distribution of mammalian DNA topoisomerase II is determined by its catalytically dispensable C-terminal domain.

Authors:  N Adachi; M Miyaike; S Kato; R Kanamaru; H Koyama; A Kikuchi
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

3.  Structural basis for the interaction of a hexameric replicative helicase with the regulatory subunit of human DNA polymerase α-primase.

Authors:  Bo Zhou; Diana R Arnett; Xian Yu; Aaron Brewster; Gregory A Sowd; Charlies L Xie; Stefan Vila; Dahai Gai; Ellen Fanning; Xiaojiang S Chen
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

4.  Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA.

Authors:  P Levac; T Moss
Journal:  Chromosoma       Date:  1996-10       Impact factor: 4.316

Review 5.  Okazaki fragment metabolism.

Authors:  Lata Balakrishnan; Robert A Bambara
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-02-01       Impact factor: 10.005

Review 6.  Mechanisms of DNA replication termination.

Authors:  James M Dewar; Johannes C Walter
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-24       Impact factor: 94.444

7.  Targeted inhibition of Replication Protein A reveals cytotoxic activity, synergy with chemotherapeutic DNA-damaging agents, and insight into cellular function.

Authors:  Sarah C Shuck; John J Turchi
Journal:  Cancer Res       Date:  2010-04-15       Impact factor: 12.701

8.  Model system for DNA replication of a plasmid DNA containing the autonomously replicating sequence from Saccharomyces cerevisiae.

Authors:  Y Ishimi; K Matsumoto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

9.  Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain.

Authors:  A Kathleen McClendon; Amanda C Gentry; Jennifer S Dickey; Marie Brinch; Simon Bendsen; Anni H Andersen; Neil Osheroff
Journal:  Biochemistry       Date:  2008-12-16       Impact factor: 3.162

10.  Effect of ICRF-193, a novel DNA topoisomerase II inhibitor, on simian virus 40 DNA and chromosome replication in vitro.

Authors:  Y Ishimi; R Ishida; T Andoh
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.